Funding Search - Pivot

The University of Vermont, through Sponsored Project Administration (SPA) subscribes to Pivot, a web-based funding search tool. The UVM Cancer Center has collaborated with SPA to create a customized cancer relevant pivot search. Press the button for Cancer Funding Opportunities.

Cancer Funding Opportunities

If you would prefer to set up your own pivot search and automated alerts you can learn more about pivot HERE.

For Pivot Assistance

Please review the information provided by SPA

Hilda Alajajian, Grant Resources Specialist is available to meet with individuals or groups for assistance in identifying funding

Phone: (802)656-1322

Should you learn of an opportunity not listed here but important to UVM Cancer Center research, please contact Laura Gordon.

Limited Competition Funding

Please contact Edward North for information on applying for Limited Funding Opportunities. 

Peer-Reviewed Funding Sources

Below is a list of fund sources from federal agencies, non-profit foundations and regional and national organizations to support cancer research are provided below for UVM Cancer Center researchers. This of funding is considered NCI approved peer-reviewed funding and can also be found in PDF format at the following link: NCI Peer-Reviewed Fund Sources

  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex’s Lemonade Stand Foundation (ALSF)
  3. American Association of Cancer Research (AACR)
  4. American Cancer Society (ACS) (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA) (excluding local/regional & “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program (NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *

Highlights: New & Updated

New and Updated
New Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R-01 - Clinical Trial Not Allowed) (R-21 - Clinical Trial Not Allowed) Epidemiologic research should seek to expand our understanding of the etiology of the malignancy, including expanding investigations on unanswered questions related to viral hepatitis-associated liver cancer, and exploring emerging and novel risk factors that may contribute to the rising burden of liver cancer in the U.S. Standard Deadlines.
New National Cancer Institute(NCI)/NIH/DHHS – Cancer Moonshotâ„  Funding Opportunities 17 new funding opportunities Application due dates vary by program.
New Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) (R03 Clinical Trial Not Allowed) (R21 Clinical Trial Not Allowed) Research should further understanding of 1) the early-life (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) factors that are associated with later cancer development; 2) how early-life factors mediate biological processes relevant to carcinogenesis; and 3) whether predictive markers for cancer risk based on what happens biologically at early life can be measured and developed for use in cancer prevention strategies. Standard Deadlines.
The Honorable Tina Brozman Foundation for Ovarian Cancer Research Individual Investigator Awards Tina's Wish is dedicated to funding groundbreaking research for early detection and prevention of ovarian cancer. Learn more at or see the grant details HERELOI due March 27th.  
New Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF) Pediatric Oncology Student Training (POST) provides an opportunity for students to train with a mentor who is conducting research in the field of pediatric oncology during the summer break. Applications are due April 1, 2018 (11:59 PM ET).
New Children’s Leukemia Research Association – Any doctor in the United States at the Ph.D. or MD level who is involved in research towards finding the causes and cure for leukemia may apply.Deadline is June 30, 2018.